NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
47 hedge funds and large institutions have $160M invested in NexImmune, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 7 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 8
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
35% more capital invested
Capital invested by funds: $118M → $160M (+$42M)
12% more funds holding
Funds holding: 42 → 47 (+5)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.55M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.27M |
| 3 |
First Manhattan
New York
|
+$1.97M |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$1.58M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$7.9M |
| 2 |
DP
DSAM Partners
London,
United Kingdom
|
-$1.46M |
| 3 |
JHU
Johns Hopkins University
Baltimore,
Maryland
|
-$439K |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$370K |
| 5 |
Morgan Stanley
New York
|
-$366K |
NEXI Hedge Fund Activity: Q3 2021 in Review
47 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q3 2021, worth a combined $160M — up 35% from $118M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NEXI positions and 7 closed out — a net gain of 5 holders — while 20 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $6.55M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $7.9M.
- 47 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q3 2021, up from 42 in Q2 2021.
- Funds reported $160M of NexImmune, Inc. Common Stock stock for Q3 2021, up 35% quarter-over-quarter.
- 12 funds opened new NexImmune, Inc. Common Stock positions in Q3 2021 and 7 closed out, a net change of +5 holders.
- The largest NexImmune, Inc. Common Stock buyer in Q3 2021 was BlackRock, an estimated $6.55M added.
- The largest NexImmune, Inc. Common Stock seller in Q3 2021 was ArrowMark Colorado Holdings, an estimated $7.9M sold.
Based on aggregated 13F filings for Q3 2021.